QIAGEN NV EO -,01
Stock
Stock
ISIN: NL0015002SN0
Ticker: QGEN
NL0015002SN0
QGEN
Price
Price
CHART BY
Frequently asked questions
What is QIAGEN NV EO -,01's market capitalization?
The market capitalization of QIAGEN NV EO -,01 is $9.99B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is QIAGEN NV EO -,01's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for QIAGEN NV EO -,01 is 24.75. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for QIAGEN NV EO -,01?
QIAGEN NV EO -,01's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.951. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for QIAGEN NV EO -,01's stock?
Currently, 23 analysts cover QIAGEN NV EO -,01's stock, with a consensus target price of $53.44. Analyst ratings provide insights into the stock's expected performance.
What is QIAGEN NV EO -,01's revenue over the trailing twelve months?
Over the trailing twelve months, QIAGEN NV EO -,01 reported a revenue of $2.07B.
What is the EBITDA for QIAGEN NV EO -,01?
QIAGEN NV EO -,01's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $734.13M. EBITDA measures the company's overall financial performance.
What is the free cash flow of QIAGEN NV EO -,01?
QIAGEN NV EO -,01 has a free cash flow of $478.88M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does QIAGEN NV EO -,01 have, and what sector and industry does it belong to?
QIAGEN NV EO -,01 employs approximately 5,765 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
Financials
- Market Cap
- $9.99B
- EPS (TTM)
- $1.951
- P/E ratio (TTM)
- 24.75
- Revenue (TTM)
- $2.07B
- EBITDA (TTM)
- $734.13M
- Free Cashflow (TTM)
- $478.88M
Pricing
- 1D span
- $47.74$49.01
- 52W span
- $35.29$51.59
Analyst Ratings
The price target is $53.44 and the stock is covered by 23 analysts.
Buy
8
Hold
15
Sell
0
Information
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
- Employees
- 5,765
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- NL0015002SN0
- Primary Ticker
- QGEN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet